Timothy Rolph - Net Worth and Insider Trading
Timothy Rolph Net Worth
The estimated net worth of Timothy Rolph is at least $6 Million dollars as of 2024-11-05. Timothy Rolph is the Chief Scientific Officer of Akero Therapeutics Inc and owns about 180,705 shares of Akero Therapeutics Inc (AKRO) stock worth over $6 Million. Details can be seen in Timothy Rolph's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy Rolph has not made any transactions after 2024-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy Rolph
Timothy Rolph Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy Rolph owns 1 companies in total, including Akero Therapeutics Inc (AKRO) .
Click here to see the complete history of Timothy Rolph’s form 4 insider trades.
Insider Ownership Summary of Timothy Rolph
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2024-09-10 | Chief Scientific Officer |
Timothy Rolph Latest Holdings Summary
Timothy Rolph currently owns a total of 1 stock. Timothy Rolph owns 180,705 shares of Akero Therapeutics Inc (AKRO) as of September 10, 2024, with a value of $6 Million.
Latest Holdings of Timothy Rolph
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2024-09-10 | 180,705 | 32.29 | 5,834,964 |
Holding Weightings of Timothy Rolph
Timothy Rolph Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy Rolph has made a total of 14 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 537 shares on September 10, 2024, which brought Timothy Rolph around $14,059.
Insider Trading History of Timothy Rolph
- 1
Timothy Rolph Trading Performance
Timothy Rolph Ownership Network
Ownership Network List of Timothy Rolph
Ownership Network Relation of Timothy Rolph
Timothy Rolph Owned Company Details
What does Akero Therapeutics Inc do?
Who are the key executives at Akero Therapeutics Inc?
Timothy Rolph is the Chief Scientific Officer of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include director & President & CEO Andrew Cheng , Chief Development Officer Catriona Yale , and Chief Operating Officer Jonathan Young .
Akero Therapeutics Inc (AKRO) Insider Trades Summary
Over the past 18 months, Timothy Rolph made 7 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 83,290. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 171,998 shares made by Jonathan Young , a net sale of 443,502 shares made by Andrew Cheng , and a net sale of 140,584 shares made by Catriona Yale .
In summary, during the past 3 months, insiders sold 478,023 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 478,023 shares. During the past 18 months, 1,227,763 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 92,237 shares.
Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akero Therapeutics Inc Insider Transactions
Timothy Rolph Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy Rolph. You might contact Timothy Rolph via mailing address: C/o Akero Therapeutics, Inc., 170 Harbor Way, 3rd Floor, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
